Significative role of edoxaban on endotelial cell functions

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Miss Cristina Almenglo

Instituto de Investigacion Sanitaria de Santiago, Santiago de Compostela (Spain)

6 More presentations in this session

Presentation thumbnail

microRNA-17-5p and microRNA-20a-5p downregulation by atorvastatin in Hepg2 cells: a new mechanism involved in the lipid-lowering therapy

Assistant Professor K. Saavedra (Temuco, CL)

Presentation thumbnail

Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus

Doctor P. Nikolaou (Athens, GR)

Abstract Slides

Presentation thumbnail

Atorvastatin and fenofibrate exert opposite effects on the vascularization and characteristics of visceral adipose tissue

Doctor O. Perez-Mendez (Mexico City, MX)

Abstract Slides

Presentation thumbnail

The pineal hormone melatonin inhibits doxorubicin-induced mitochondrial dysfunction and apoptosis in cardiomyocytes

Miss T. Kasi Ganeshan (London, GB)

Presentation thumbnail

Acute Cardio-Selective Functional Modulation via a Small-Molecule Direct Myosin-Attenuator (MYK-581) Preserves Diaphragmatic Function in vivo: Comparison versus Disopyramide

Doctor C. del Rio (Brisbane, US)

Access the full session

Session thumbnail

Poster Session 5 - Mechanisms underlying pharmacotherapy

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

Congress Presentation

Direct oral anticoagulants or warfarin in patients with left ventricular thrombus: a meta-analysis of randomized clinical trials

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources